Melinta Therapeutics
Melinta Therapeutics Initiates Phase 3 Registration Study of Delafloxacin in Individuals with Uncomplicated Gonorrhea
January 09, 2014 08:00 ET | Melinta Therapeutics
NEW HAVEN, Conn, Jan. 9, 2014 (GLOBE NEWSWIRE) --  Melinta Therapeutics today announced the initiation of a Phase 3 trial of delafloxacin, a novel investigational fluoroquinolone, for the...
Melinta Therapeutics
Melinta Therapeutics Bolsters Executive Team with Appointment of Paul Estrem as Chief Financial Officer
December 02, 2013 08:00 ET | Melinta Therapeutics
NEW HAVEN, Conn, Dec. 2, 2013 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced the appointment of Paul Estrem to the role of chief financial officer.  Mr. Estrem brings more than 20 years...
Melinta Therapeutics
Melinta Therapeutics Prepares for Late-Stage Product Launches with Appointment of Sue Cammarata, M.D. as Chief Medical Officer
November 19, 2013 08:00 ET | Melinta Therapeutics
NEW HAVEN, Conn, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced the appointment of Sue Cammarata, M.D. as chief medical officer.  In this role, Dr. Cammarata will be...
Cran-Max Effective Prevention in High Risk Cases of UTI
October 23, 2013 15:21 ET | Cran-Max
KEARNY, NJ--(Marketwired - Oct 23, 2013) - Urinary tract infections (UTI) are responsible for more than 7 million doctor visits a year. Although UTIs can be treated in the short term with...
Melinta Therapeutics
Melinta Therapeutics Expands Leadership Team with Appointment of Lyn Baranowski as SVP of Corporate Development and Strategy
October 07, 2013 10:00 ET | Melinta Therapeutics
NEW HAVEN, Conn, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced the appointment of Lyn Baranowski as senior vice president, corporate development and strategy.  In this...
Fedora Pharmaceutica
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
September 12, 2013 13:00 ET | Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented results of preclinical studies demonstrating that FPI-1465 increases the activity of...
Fedora Pharmaceutica
Fedora Pharmaceuticals Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
August 27, 2013 08:00 ET | Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that the Company and its collaborators will be presenting 10 posters at the upcoming Interscience...
NorthShore University HealthSystem Study Finds Physicians Often Use Inexact Data When Deciding to Prescribe Antibiotics
August 06, 2012 17:07 ET | NorthShore University HealthSystem
EVANSTON, Ill., Aug. 6, 2012 (GLOBE NEWSWIRE) -- The over-use of antibiotics is a major public health concern, and a new study by NorthShore University HealthSystem (NorthShore) found that physicians...
American Heart Association Logo
OK to Limit Pre-Dental Procedure Antibiotics to High Risk Heart Patients
June 11, 2012 16:00 ET | American Heart Association
Study Highlights: The incidence of infective may not have increased after the American Heart Association changed its recommendations on the use of antibiotics before invasive dental...
Alliance for the Prudent Use of Antibiotics Lauds FDA for Action on Antimicrobial Drugs in Food-Producing Animals
June 29, 2010 13:23 ET | APUA
BOSTON, MA--(Marketwire - June 29, 2010) -  The Alliance for the Prudent Use of Antibiotics (APUA), the leading, independent global organization dedicated to preserving the power of existing...